Patent Pools for CRISPR Technology — Response
Science, Vol. 355(6331), pp. 1274-1275 (2017)
Posted: 28 Jun 2017 Last revised: 13 Nov 2019
Date Written: March 24, 2017
Abstract
In response to a letter from Lawrence Horn, MPEG LA, suggesting patent pools for CRISPR licensing, we respond that while patent pools have been successfully deployed in the consumer electronics and other markets, we question whether patent pooling would offer the optimal balance of openness and incentive for CRISPR therapeutics.
Keywords: crispr, licensing, biotechnology, intellectual property, patents, pools, mpegla, genetics
JEL Classification: K00, K23, K41, O3, O34, D23, K11
Suggested Citation: Suggested Citation
Contreras, Jorge L. and Sherkow, Jacob S., Patent Pools for CRISPR Technology — Response (March 24, 2017). Science, Vol. 355(6331), pp. 1274-1275 (2017), Available at SSRN: https://ssrn.com/abstract=2993176
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.